IDEAYA Biosciences
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- IDEAYA Biosciences
- Company name
- IDEAYA Biosciences
- Organisation type
- Industry
- Registered legal name
- IDEAYA BIOSCIENCES, INC.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001676725
- Legal Entity Identifier (LEI)
- 549300ULW08F62IJML11
Related records
Trials (11)
- (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
- A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
- A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
- Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion